NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB | NIH: National Institute of Allergy and Infectious Diseases

NIH Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB | NIH: National Institute of Allergy and Infectious Diseases

Tuesday, June 25, 2019 NIAID Launches Large TB Prevention Trial for People Exposed to Multidrug-Resistant TB A large clinical trial to assess treatments for preventing people at high risk from developing multidrug-resistant tuberculosis (MDR-TB) has begun. The study is comparing the safety and efficacy of a new MDR-TB drug, delamanid, with the decades-old TB drug isoniazid for preventing active MDR-TB disease in children, adolescents and adults at high risk who are exposed to adult household members with MDR-TB.